About

Dr. Jessica A. Johnson, psychiatric nurse practitioner and founder of a specialty psychiatry practice for OCD, ADHD and tic disorders.

A Columbia-trained board-certified psychiatric nurse practitioner, Dr. Johnson is highly trained in specialty areas including OCD, ADHD, tic disorders and other related conditions. She has extensive experience with complex and treatment-resistant presentations.

Jessica Johnson, DNP, PMHNP-BC

Education & Training

Columbia University

  • Doctorate of Nursing Practice (DNP)

    • Psychiatric mental health nurse practitioner specialty (PMHNP)

    • ANCC Board Certification, psychiatric mental health (PMHNP-BC)

  • Masters of Science in Nursing (MSN) 

    • Registered Nurse (RN)

Syracuse University - Go Orange!

  • Bachelor of Science (BS) - Psychology, Neuroscience

Clinical Research & Depth

Yale Child Study Center

TS/OCD/ADHD Specialty Clinic - Yale School of Medicine

Dr. Johnson has over a decade of experience within the Yale community, including early research roles, a postgraduate fellowship and several years on clinical faculty as an advanced practice psychiatric nurse. She has evaluated and treated complex and treatment-resistant cases across child, adolescent and adult populations.

Dr. Johnson has also served as a sub-investigator on multiple industry-sponsored clinical trials involving tic disorders, OCD, depression, anxiety and school refusal, including early-phase studies of emerging treatments such as esketamine (Spravato) and ecopipam.

  • Beyer, C., Cappetta, K., Johnson, J. A., & Bloch, M. H. (2017). Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants. Depression and Anxiety, 34(12), 1134–1146. https://doi.org/10.1002/da.22680 

    Bloch, M. H., Landeros-Weisenberger, A., Johnson, J. A., & Leckman, J. F. (2021). A phase-2 pilot studyofatherapeuticcombinationofΔ9−tetrahydracannabinolandpalmitoylethanolamideforadults with Tourette’s syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences, 33(4), 328–336.https://doi.org/10.1176/appi.neuropsych.19080178

    Cappetta K., Beyer C., Johnson J.A., & Bloch M.H. (2017). Meta-analysis: Risk of dry mouth with second generation antidepressants. Progress in Neuropsychopharmacology and Biological Psychiatry, 84(Pt A), 282–293. https://doi.org/10.1016/j.pnpbp.2017.12.012

    Dwyer, J. B., Landeros-Weisenberger, A., Johnson, J. A., Londono Tobon, A., Flores, J. M., Nasir, M., Couloures, K., Sanacora, G., & Bloch, M. H. (2021). Efficacy of intravenous ketamine in adolescent treatment-resistant depression: A randomized midazolam-controlled trial. The American Journal of Psychiatry, 178(4), 352–362. https://doi.org/10.1176/appi.ajp.2020.20010018

    Farhat, L. C., Vattimo, E., Ramakrishnan, D., Levine, J., Johnson, J. A., Artukoglu, B. B., Landeros- Weisenberger, A., Asbahr, F. R., Cepeda, S. L., Comer, J. S., Fatori, D., Franklin, M. E., Freeman, J. B., Geller, D. A., Grant, P. J., Goodman, W. K., Heyman, I., Ivarsson, T., Lenhard, F., Lewin, A. B., … Bloch, M. H. (2021). Systematic review and meta-analysis: An empirical approach to defining treatment response and remission in pediatric obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, S0890-8567(21)01843-8. Advance online publication. https://doi.org/10.1016/j.jaac.2021.05.027

    Jakubovski, E., Johnson, J.A., Nasir, M., & Bloch, M.H. (2019). Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety, 36(3), 198–212. https://doi.org/10.1002/da.22854

    Johnson, J. A., Jakubovski, E., Reed, M. O., & Bloch, M. H. (2017). Predictors of long-term risky driving behavior in the Multimodal Treatment Study of Children with Attention- Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 27(8), 747–754. https://doi.org/10.1089/cap.2017.0025

    Kuang, H., Johnson, J. A., Mulqueen, J. M., & Bloch, M. H. (2017). The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysis. Depression and Anxiety, 34(10), 888-896. https://doi.org/10.1002/da.22643

    Li, F., Welling, M.C., Johnson, J. A., Coughlin, C., Mulqueen, J., Jakubovski, E., Coury, S., Landeros Weisenberger, A., & Bloch, M.H. (2020). N-acetylcysteine for pediatric obsessive-compulsive disorder: A small pilot study. Journal of Child and Adolsecent Psychopharmacology, 30(1), 32- 37. https://doi.org/10.1089/cap.2019.0041

    Reed, M. O., Jakubovski, E., Johnson, J. A., & Bloch, M. H. (2017). Predictors of long-term school- based behavioral outcomes in the Multimodal Treatment Study of Children with Attention- Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 27(4), 296-309. https://doi.org/10.1089/cap.2015.0168

    Taylor, J. H., Landeros-Weisenberger, A., Coughlin, C., Mulqueen, J., Johnson, J. A., Gabriel, D., Reed, M. O., Jakubovski, E., & Bloch, M. H. (2017). Ketamine for social anxiety disorder: A randomized, placebo-controlled crossover trial. Neuropsychopharmacology. https://doi.org/10.1038/npp.2017.194

    van Schalkwyk, G. I., Beyer, C., Johnson, J., Deal, M., & Bloch, M. H. (2017). Antipsychotics for aggression in adults: A meta-analysis. Progress in Neuropsychopharmacology and Biological Psychiatry, 81, 452–458. https://doi.org/10.1016/j.pnpbp.2017.07.019

    van Schalkwyk, G. I., Beyer, C., Johnson, J., van Rensburg, S., & Bloch, M. H. (2017). Efficacy of antipsychotics for irritability and aggression in children: A meta-analysis. Expert Review of Neurotherapeutics, 17(10), 1045–1053. https://doi.org/10.1080/14737175.2017.1371012

  • “Well… it only took 25 years for someone to finally figure that out.”

    —Adult Patient

  • “I didn’t cry at all this week. Not even once!”

    —Child (age 8)

  • “She asked me every day this week how many days until we see Dr. J again.”

    —Parent of 9-year-old

  • “I was having a parent panic spiral — this was the conversation I needed.”

    —Parent of 8-year-old

Connect with Dr. Johnson

Get in Touch